CClinicalTrials.gg
CompletedNCT03903536TEHUpdated Jul 18, 2023

Thrombosed External Hemorrhoids: Comparison of the Thrombectomy and Local Excision Procedures in Terms of Results and Outcome (TEH)

An observational study in Thrombosed External Hemorrhoid, sponsored by Gazi University. Completed at 2 sites in Turkey. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-07-18.

Sponsored by Gazi University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
96
Ages
18 Years and older
Sex
All
01

Study summary

The primary aim of the current study is to evaluate and compare 6-month complication rates after thrombectomy and local excision treatments.

The investigators aim to compare thrombectomy and local excision treatments in many different aspects:

  • The investigators will follow these patients for 6 months by scheduling follow-up visits (or by phone if the patient cannot attend) 4 times during this period (1st week, 1st month, 3rd month, 6th month).
  • The investigators will examine bleeding, pain, anal stricture/stenosis, infection, time until return to normal daily activity, relapse and incontinence after treatment
  • To assess quality of life outcomes, the investigators use the 36-Item Short Form Health Survey (SF-36). These measures rely upon patient self-reporting and are utilized for routine monitoring and assessment of care outcomes in patients.
  • The investigators will use the Wexner incontinence score for assessment of incontinence.

In each hospital, medical students, residents and surgeons can be involved in the study. In the following 6-month period, all collaborators will be collecting the data of the patients who have been operated for external hemorrhoids via the thrombectomy or local excision procedures.

02

Conditions studied

  • Thrombosed External Hemorrhoid
03

In context

Hemorrhoids

221 studies on the registry are indexed under Hemorrhoids; 64 are open to participants now.

This study's enrollment of 96 is below the median of 200 across 47 observational studies indexed under Hemorrhoids.

Browse Hemorrhoids studies →

Lead sponsor

Gazi University is the lead sponsor of 531 studies on the registry; 99 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients who apply (or are referred) to general surgery departments and are diagnosis with thrombosed external hemorrhoids will be included in the study.

Inclusion criteria

  • Patients who are diagnosis with thrombosed external hemorrhoids.
  • Providing a written informed consent form for the surgeries and for participation in the study
  • Patients aged 18 years and over should be included

Exclusion criteria

Exclusion Criteria:

  • Patients younger than 18 years of age,
  • Pregnancy
  • Patients who have a history of cancer or inflammatory bowel disease(IBD)
  • Patients who have a history of anorectal fistula
  • Patients with metabolic disorders
  • Patients with alcohol or substance addiction
  • Patients who refuse to participate in the study and do not provide informed consent
  • Patients who, at any stage of the study, indicate that they want to leave the study.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
96 participants (actual)
Target follow-up
6 Months
Patient registry
Yes

Groups and cohorts

  • Thrombectomy

    Patients with thrombosed external hemorrhoids undergoing thrombectomy

    Procedure: Thrombectomy

  • Local excision/ Hemorrhoidectomy

    Patients with thrombosed external hemorrhoids undergoing local excision/ hemorrhoidectomy

    Procedure: Hemorrhoidectomy

Interventions

  • ProcedureThrombectomy

    A small procedure where surgeons make a cut in the hemorrhoid and drain the blood.

  • ProcedureHemorrhoidectomy

    A surgery to remove the hemorrhoid, including the blood vessels and clot.

06

What researchers measure

Primary outcomes

  1. 6-month complication rate

    * The investigators will follow these patients for 6 months by scheduling follow-up visits (or by phone if the patient cannot attend) 4 times during this period (1st week, 1st month, 3rd month, 6th month). * The investigators will examine anal bleeding(exist or not), pain(exist or not), anal stricture/stenosis(exist or not, its severity), infection(exist or not), time until return to normal daily activity, relapse and incontinence after treatment. * The investigators will use the Wexner incontinence score for assessment of incontinence. * The investigators will measure the internal diameter of anal canal for the assessment of anal stenosis and its severity. When the internal diameter of anal canal is less than 0.5 cm, it is severe stenosis and when the diameter is 0.5-1 cm stenosis is moderate and 1-1.5 cm diameter is known as mild stenosis.

    Time frame: 6 months from operation

  2. 6-month quality of life outcomes

    Quality of life outcomes within 6 months of surgical procedure. To assess quality of life outcomes, the investigators use the 36-Item Short Form Health Survey (SF-36). The SF-36 has eight scaled scores; the scores are weighted sums of the questions in each section. Scores range from 0 - 100. Lower scores = more disability, higher scores = less disability. Sections: * Vitality * Physical functioning * Bodily pain * General health perceptions * Physical role functioning * Emotional role functioning * Social role functioning * Mental health

    Time frame: 6 months from operation

07

Study locations

2 sites
  • Gazi University
    Ankara, 06560, Turkey
  • Yildirim Beyazit University Yenimahalle Training and Research Hospital
    Ankara, 06560, Turkey
08

References and documents

Individual participant data

Plan to share: Yes — Derived anonymised data at the patient-level may be able to be made available for sharing

Supporting information: Study protocol, Sap

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 18, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03903536
Lead sponsor
Gazi University
Responsible party
Ali Yalcinkaya (Principal Investigator, Gazi University) — Principal investigator
First posted
Apr 4, 2019
Start date
Sep 1, 2020
Primary completion
Sep 1, 2021
Completion
Jun 1, 2022
Last update
Jul 18, 2023

Study contacts

Sezai Leventoglu, Professor
study chair · Gazi University Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion